Evidence map›Paper›PMID 42098654›Full record

ArticleBMC cancer2026

SPINK4 affected M2 macrophage polarization to promote colorectal cancer malignant phenotype by PI3K/AKT pathway.

Mingxiao Cao, Jiaqi Hao, Lixin Jiang

Abstract read
In one paragraph

Article in BMC cancer, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors.

Mingxiao Cao *Yantai Yuhuangding Hospital, Shandong University, Yantai, China.
Jiaqi Hao *Gastrointestinal Surgery, Yantai Yuhuangding Hospital, Yantai, China.
Lixin JiangYantai Yuhuangding Hospital, Shandong University, Yantai, China. jianglixin19691001@163.com.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

This study aimed to elucidate the oncogenic role of SPINK4 in colorectal cancer (CRC) and its underlying mechanism regulating macrophage polarization in the tumor microenvironment. In vitro, we constructed SPINK4-overexpressing and SPINK4-knockdown CRC cell lines (HT29 and HCT116) to evaluate their effects on cell proliferation, migration, and invasion. We then established a macrophage-CRC cell co-culture system to explore whether SPINK4 promotes macrophage recruitment and M2 polarization. Mechanistically, we not only regulated the PI3K/AKT pathway using inhibitor LY294002 and activator 740Y-P but also specifically knocked down PI3K via small interfering RNA (siRNA) to confirm if SPINK4's function depends on this pathway. In vivo, we established HCT116 xenograft models in nude mice, monitored tumor volume and weight, evaluated tumor proliferation by Ki67 immunohistochemistry, quantified tumor-infiltrating macrophages by flow cytometry, and detected M1/M2 macrophage marker expression by RT-qPCR. Experimental results showed SPINK4 overexpression significantly enhanced CRC cell proliferation, migration, and invasion, induced macrophage recruitment and M2 polarization, and upregulated IL-33, IL-4, IL-10, CSF1, CCL2, and VEGF-C secretion. Inhibiting PI3K/AKT reversed these effects. In vivo, SPINK4 overexpression activated PI3K/AKT, promoting tumor growth and M2 macrophage infiltration. Collectively, SPINK4 acts as an oncogene to promote macrophage recruitment and M2 polarization via PI3K/AKT, driving CRC malignant progression.

Indexed as

Colorectal NeoplasmsMacrophagesPhosphatidylinositol 3-KinasesProto-Oncogene Proteins c-aktAnimalsCell Line, TumorCell MovementCell ProliferationHCT116 CellsHumansMacrophage ActivationMiceMice, NudePhenotypeSignal TransductionTumor-Associated MacrophagesPhosphatidylinositol 3-KinasesProto-Oncogene Proteins c-aktColorectal cancerPI3K/AKT pathwayPolarization and recruitmentSPINK4Tumor associated macrophages (TAMs)

Identifiers

PMID42098654
PMCPMC13501570

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.